Accessibility Menu
Oxford Nanopore Technologies Plc logo

Oxford Nanopore Technologies Plc(LSE) ONT

Current Price£1.11
Market Cap£1.08BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-82%
5 YearN/A
1 Year-37%
1 Month-5%
Oxford Nanopore Technologies Plc last closing stock price
MetricPriceDate
Last closeGBX 110.702026-07-21
Oxford Nanopore Technologies Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.06%GBX 116.602026-07-14
1 month-4.98%GBX 116.502026-06-19
3 month-8.36%GBX 120.802026-04-22
Year to date-13.79%GBX 128.402025-12-31
1 year-36.67%GBX 174.802025-07-21
3 year-59.33%GBX 272.202023-07-21
Since inception-82.04%GBX 6.132021-09-30

Oxford Nanopore Technologies Plc Financials at a Glance

Market Cap

£1.08BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£407.09M

Net Income (TTM)

-£291.39M

EPS (TTM)

-£0.15

P/E Ratio

-7.33

Dividend

£0.00

Beta (Volatility)

0.11 (Low)

Price

£1.11

Volume

942,631

Open

£1.10

Previous Close

£1.11

Daily Range

£1.09 - £1.13

52-Week Range

£0.96 - £2.25

Estimated Earnings Date

Aug 19, 2026

ONT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc is a pioneering biotechnology company based in the United Kingdom, specializing in innovative nanopore-based sensing systems for molecular analysis. The company offers a range of portable and benchtop sequencing devices, enabling real-time analysis of DNA and RNA.

Products and Services
  • MinION: A portable device for DNA and RNA sequencing
  • GridION: A benchtop sequencer for multiple flow cells
  • EPI2ME: A cloud-based platform for real-time data analysis
Growth Outlook
  • Recent quarterly revenue reached £171.1 million, indicating strong market demand
  • Continued investment in R&D, with £75.65 million allocated last quarter
  • Expansion of product offerings, including new devices like MinION Mk1D and Ubi
Financial Highlights
  • Trailing twelve months (TTM) revenue of £336.5 million, showcasing growth potential
  • Current ratio of 3.56, indicating strong liquidity position
  • Net income for the latest quarter was -£109.3 million, reflecting ongoing investment in growth
Oxford Nanopore Technologies is positioned at the forefront of the biotechnology sector, leveraging its unique technology to meet the growing demand for genomic analysis. The company's diverse product range, including portable and benchtop sequencers, caters to various market needs, from research institutions to clinical applications. With a robust growth outlook supported by significant R&D investments, Oxford Nanopore is well-equipped to capitalize on emerging opportunities in the genomics field. The financial metrics indicate a strong liquidity position, although the company is currently operating at a net loss as it invests heavily in future growth. This strategic focus on innovation and expansion may appeal to investors looking for long-term growth potential in the biotechnology sector.
AI Generated • Jul 21, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

1,403

CEO

Gordon Sanghera, PhD

Website

nanoporetech.com

Headquarters

Oxford, OX OX4 4DQ, GB

ONT Financials

Key Financial Metrics (TTM)

Gross Margin

58.64%

Operating Margin

-69.36%

Net Income Margin

-64.85%

Return on Equity

-29.43%

Return on Capital

-30.76%

Return on Assets

-23.33%

Earnings Yield

-13.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£1.08BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

975.25M

Volume

942.63K

Avg. Volume

1.40M

Financials (TTM)

Gross Profit

£236.70M

Operating Income

-£307.63M

EBITDA

-£244.13M

Operating Cash Flow

-£147.62M

Capital Expenditure

-£16.24M

Free Cash Flow

-£168.93M

Cash & ST Invst.

£255.30M

Total Debt

£41.50M

Oxford Nanopore Technologies Plc Performance Analysis

Oxford Nanopore Technologies Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 198,603,00048.6%
20232023-12-31GBP 169,668,000-14.6%
20242024-12-31GBP 183,191,0008.0%
20252025-12-31GBP 223,900,00022.2%
Oxford Nanopore Technologies Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-300.5%
Q42024-12-3117.9%
Q22025-06-30-46.7%
Q42025-12-31224.1%
Oxford Nanopore Technologies Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.11-45.8%
20232023-12-31GBP -0.1967.7%
20242024-12-31GBP -0.16-12.1%
20252025-12-31GBP -0.15-7.2%
Oxford Nanopore Technologies Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3013.4%
Q42024-12-3111.5%
Q22025-06-3051.0%
Q42025-12-31-193.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£171.10M

+104.5%

Gross Profit

£100.60M

+145.8%

Gross Margin

58.80%

N/A

Market Cap

£1.08BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£781.19K

N/A

Employees

1,382

N/A

Net Income

-£109.30M

-29.5%

EBITDA

-£72.40M

-20.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£255.30M

-5.5%

Total Debt

£41.50M

-0.4%

Accounts Receivable

£52.50M

+24.0%

Inventory

£81.50M

-19.7%

Long Term Debt

£36.30M

-2.8%

Short Term Debt

£5.20M

-39.8%

Return on Assets

-23.33%

N/A

Return on Invested Capital

-30.78%

N/A

Free Cash Flow

-£19.70M

+76.3%

Operating Cash Flow

-£18.60M

+76.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNS.LGenus plc
£21.20-0.56%
OXB.LOxford Biomedica plc
£6.03-0.82%
AVCT.LAvacta Group Plc
£0.67-0.74%
SCLP.LScancell Holdings plc
£0.14+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$7.66+0.11%
NVDANvidia
$207.29+0.02%
NOKNokia
$10.63+0.05%
MARAMara Holdings
$12.25+0.05%

Questions About ONT

What is the current price of Oxford Nanopore Technologies Plc?

Oxford Nanopore Technologies Plc is trading at £1.11 per share.

What is the 52-week range for Oxford Nanopore Technologies Plc?

Over the past 52 weeks, Oxford Nanopore Technologies Plc has traded between £0.96 and £2.25.

How much debt does Oxford Nanopore Technologies Plc have?

As of the most recent reporting period, Oxford Nanopore Technologies Plc reported total debt of £41.50M.

How much cash does Oxford Nanopore Technologies Plc have on hand?

Oxford Nanopore Technologies Plc reported £181.10M in cash and cash equivalents in its most recent financial results.

What is Oxford Nanopore Technologies Plc’s dividend yield?

Oxford Nanopore Technologies Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services